Celu­lar­i­ty signs on to do con­tract re­search for Re­gen­eron

Celu­lar­i­ty an­nounced Tues­day morn­ing that it will do con­tract re­search for Re­gen­eron on the Tar­ry­town, NY-based com­pa­ny’s “off-the-shelf” CAR-T cell ther­a­pies. Af­ter a rough year …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER